The predictive value of CHADS2 score for subclinical cerebral ischemia after carotid artery stenting (from the PREVENT-CAS trial).
Ömer ÇelikAhmet GunerMacit KalçıkArda GülerAli Rıza DemirYusuf DemirBegum UygurAhmet Anıl ŞahinÇağdaş TopelMehmet ErtürkPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2020)
CHADS2 score was able to predict the risk of periprocedural subclinical ischemic events in CAS and might be of clinical value in the management of patients with carotid artery stenosis.
Keyphrases
- cerebral ischemia
- crispr cas
- genome editing
- subarachnoid hemorrhage
- blood brain barrier
- brain injury
- study protocol
- clinical trial
- percutaneous coronary intervention
- phase iii
- randomized controlled trial
- ischemia reperfusion injury
- oxidative stress
- direct oral anticoagulants
- coronary artery disease
- venous thromboembolism